Key result
HeartMate 3 shows potential as viable long-term mechanical circulatory support in pediatric heart failure.
Why the study?
Children with heart failure have limited mechanical circulatory support options and a high incidence of embolic events, necessitating evaluation of new devices.
The HeartMate 3 may offer a viable long-term mechanical circulatory support option with favorable hemocompatibility for pediatric heart failure patients.
May expand pediatric MCS options; hypothesis-generating and requires prospective trials before practice change.
Children with heart failure have few mechanical circulatory support options and have a high incidence of embolic events. The favorable hemocompatibility and smaller profile of HeartMate 3 may provide more long-term options for the pediatric population.
No takes yet. Share an insight, caveat, or question.
Bansal et al. (2019) studied this question. HeartMate 3 implantation may provide a viable long-term mechanical circulatory support option for pediatric heart failure patients due to its favorable hemocompatibility and smaller profile.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: